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Abstract
Mutations in protocadherin 19 (PCDH19), which is on the X-chromosome, cause the brain disease Epilepsy in
Females with Mental Retardation (EFMR). EFMR is also often associated with autism-like symptoms. In mice and
humans, epilepsy occurs only in heterozygous females who have a mixture of PCDH19 wild-type (WT) and mutant
cells caused by random X-inactivation; it does not occur in hemizygous PCDH19 mutant males. This unique inheritance
pattern strongly suggests the underlying disease mechanism operates via interference between WT and mutant cells rather
than being a result of complete loss of PCDH19 functions. Although it remains unclear whether the other symptoms of
EFMR also conform to this unique genotype-phenotype relationship, PCDH19 mutant males were recently reported to
demonstrate autism-like symptoms. We, therefore, used a Pcdh19 knockout (KO) mouse model to ask whether a complete
lack of PCDH19 causes autism-like behaviors. Consistent with the autism observed in EFMR females, we found Pcdh19
heterozygous KO female mice (with mosaic expression of PCDH19) show defects in sociability in the 3-chamber test.
Surprisingly, hemizygous Pcdh19 KO male mice (without any PCDH19 expression) exhibit impaired sociability in the 3-
chamber test and reduced social interactions in the reciprocal social interaction test. We also observed that, compared to WT
mice, mutant mice display more repetitive behaviors, including self-grooming and rearing. These findings indicate that
hemizygous Pcdh19 KO male mice show autism-like phenotypes.
Epilepsy in Females with Mental Retardation (EFMR) is re-
portedly caused by mutations (i.e., missense, nonsense, and
deletion, etc.) in the X-linked gene protocadherin 19
(PCDH19) [1]. EFMR patients have early-onset seizures fre-
quently associated with varying degrees of intellectual disabil-
ity (ID) and autism-like symptoms [2–4]. As the name of the
disease implies, it is highly sex-limited. Epileptic symptoms
appear only in females heterozygous for PCDH19 mutations,
whereas males hemizygous for PCDH19 mutations are un-
affected carriers [5]. Because PCDH19 is X-linked, it is sub-
ject to random X-inactivation, producing mosaic expression
in heterozygous mutant females [1]. The identification of
male patients affected by postzygotic somatic PCDH19muta-
tions supports the idea that the disease mechanism is related
to mosaic expression of PCDH19 [6, 7]. This idea is further
supported by the case of an epileptic patient with Klinefelter
Syndrome (47, XXY) heterozygous for a PCDH19 mutation
[8]. This unique genotype-phenotype relationship suggests
the symptoms of EFMR emerge from the abnormal inter-
action of two different populations of brain cells, some with
and some without PCDH19 expression. This cellular mech-
anism is referred to as “cellular interference” [1, 6].
Recently, Pederick et al. [9] demonstrated a dramatic and
abnormal segregation of PCDH19(+) and PCDH19(−) cells
in the developing brains of Pcdh19 heterozygous KO female
mice that was well-correlated with seizure-like activities as
recorded by electrocorticogram. This result provided the first
experimental evidence of cellular interference as a key patho-
genic mechanism in EFMR. It is unclear, however, whether
autism spectrum disorder (ASD) in EFMR also conforms to
both this unusual inheritance pattern and cellular interfer-
ence mechanism. It is notable that recent human studies
identified some males with ASD who have mutations in
PCDH19 [3, 10, 11], suggesting PCDH19mutations may also
play a role in producing the symptoms of males with ASD
via mechanisms other than cellular interference. In this
study, we investigate this possibility using a Pcdh19 KO
mouse model.
Consistent with previous studies [9, 12], heterozygous
Pcdh19 KO female mice show an abnormal “tiger-
striped” pattern of segregation between PCDH19(+) and
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Fig. 1 Pcdh19 hemizygous KO male mice exhibit autism-like behaviors. a Representative images of tdT-expressing cells (PCDH19-negative cells) in
coronal sections of HET-tdT female and KO-tdT male brains at P56 (left). Scale bar, 200 μm. Schematic diagrams of the X and Y chromosomes of
heterozygous KO female and hemizygous KO male mice, showing tdT and Pcdh19-null alleles (in which the PCDH19 coding sequence is replaced
with a LacZ cassette) are located on the same X-chromosome; XLacZ-tdT (right). b Group-averaged heat map images for the movement of WT (X/Y)
and Pcdh19 hemizygous KO (XLacZ/Y) male mice during the 3-chamber sociability test (S1 vs O). c Quantification of the results shown as sniffing
time, based on the time spent sniffing S1 vs O in the sociability test and S1 vs S2 in the social novelty test (*p < 0.05, **p < 0.01, paired Student’s t
test). d The time of social interaction of Pcdh19 KO male mice during the reciprocal social interaction test. e-f Repetitive behavior tests: the number of
rearing incident (e) and the time spent self-grooming (f) in Pcdh19 KO male mice (*p < 0.05, **p < 0.01, ***p < 0.001, unpaired Student’s t test). n = 10–
12 male mice per genotype. All data are presented as means ± SEM
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PCDH19(−) cells in the brain (Fig. 1a). In contrast to
heterozygous Pcdh19 KO female mice, we did not ob-
serve a similar segregation in hemizygous Pcdh19 KO
male mice, despite both having a tdTomato (tdT) re-
porter gene on the X-chromosome where the Pcdh19
gene was deleted (Fig. 1a). This finding suggests any
phenotypes in hemizygous Pcdh19 KO male mice are in-
dependent of the abnormal sorting mechanism observed
in heterozygous Pcdh19 KO female mice.
First, we asked whether heterozygous Pcdh19 KO female
mice show autism-like behaviors in our experimental set-
ting (see Additional file 1 for the detailed methods). We
found that heterozygous Pcdh19 KO female mice (XLacZ/
X) do not show any preference toward exploring a novel
mouse (S1) versus a non-social novel object (O) in the 3-
chamber test (the sociability test). This suggests heterozy-
gous Pcdh19 KO female mice recapitulate the autism-like
symptoms of female EFMR patients. In the social novelty
test, in which we measured preference toward a familiar
mouse (S1) and a novel mouse (S2), we found the hetero-
zygous Pcdh19 KO mice (XLacZ/X) spend more time ex-
ploring the novel mouse (S2) (see Additional file 2).
We next examined the male mice to determine
whether they also show any social impairment. In the 3-
chamber sociability test, we found male Pcdh19 KO
(XLacZ/Y) mice spend significantly more time sniffing a
non-social novel object (O) rather than a novel mouse
(S1), suggesting abnormal sociality. Both hemizygous
males and controls, however, show similar preference to-
wards a novel mouse (S2) in the social novelty test (Fig.
1b–c). We then measured reciprocal social interactions
to confirm the social abnormalities of male Pcdh19 KO
(XLacZ/Y) mice. We found they spend significantly less
time interacting with a stranger mouse than WT (X/Y)
mice do (Fig. 1d). To determine whether male Pcdh19
KO (XLacZ/Y) mice show increased repetitive behavior—
another autism-like phenotype—we monitored their
rearing and stereotyped grooming behaviors. We found
Pcdh19 XLacZ/Y male mice spend more time rearing and
self-grooming (Fig. 1e–f) than WT (X/Y) male mice.
Thus, their abnormal social interaction results and in-
creased repetitive behaviors suggest hemizygous Pcdh19
KO (XLacZ/Y) mice show autism-like behaviors.
We do not yet know how the complete loss of Pcdh19
causes autism-like behaviors in male mice, but consider-
ing the fact that the abnormal segregation pattern occurs
only in the brain of female heterozygous Pcdh19 KO
mice [9, 13], but not in male KO mice, our present find-
ings suggest the mechanism will be distinct from the cel-
lular interference mechanism that underlies the epileptic
symptoms of EFMR. It is possible a loss of PCDH19-
mediated cell-to-cell adhesion may contribute to autism-
like behaviors in hemizygous Pcdh19 male KO mice.
PCDH19 regulates intracellular binding proteins like
NONO and the GABAA receptor alpha subunits [14,
15]. Hence, it is also possible the absence of PCDH19
disrupts the function of unidentified autism-related
binding proteins. Our social interaction results were in-
consistent with a previous study in which heterozygous
KO female and hemizygous KO male mice showed no
abnormalities in the social interaction tests [12]. In fact,
we are still unclear why the mice showed this inconsist-
ency, but we found that the background of the mouse,
the targeted exons, and the size of the behavioral appar-
atus used for the experiment were all different.
This is the first report showing, in genetically modified
mice, that autism-like behaviors induced by Pcdh19 mu-
tations are not subject to the same genotype-phenotype
relationship observed in epileptic symptoms of EFMR.
From this finding, we postulate that both mosaic expres-
sion of PCDH19 and PCDH19 insufficiency contribute
to the pathogenesis of EFMR. Considering the fact that
male patients affected by mosaic PCDH19 mutations
also show autism [6], the induction of autism in a male
patient may not require complete loss of PCDH19 in
every cell. In the future, the generation of male mice
with mosaic Pcdh19 deletions will help address the ques-
tion of whether both mosaic loss and complete loss of
PCDH19 result in autism-like behaviors.
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Supplementary information accompanies this paper at https://doi.org/10.
1186/s13041-019-0519-3.
Additional file 1. Materials and Methods.
Additional file 2: Figure S1. Pcdh19 heterozygous KO female mice
display autistic-like behaviors in the 3-chamber sociability test.
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